Selective BET inhibitor RVX‐208 ameliorates periodontal inflammation and bone loss
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective BET inhibitor RVX‐208 ameliorates periodontal inflammation and bone loss
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PERIODONTOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-19
DOI
10.1111/jcpe.13887
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BET Protein Inhibition Regulates Macrophage Chromatin Accessibility and Microbiota-Dependent Colitis
- (2022) Michelle Hoffner O’Connor et al. Frontiers in Immunology
- Influence of epigenetics on periodontitis and peri‐implantitis pathogenesis
- (2022) Lena Larsson et al. PERIODONTOLOGY 2000
- Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study
- (2021) Stephen J. Nicholls et al. Cardiovascular Diabetology
- Selective targeting of BD1 and BD2 of the BET proteins in cancer and immuno-inflammation
- (2020) Omer Gilan et al. SCIENCE
- The Nexus Between Periodontal Inflammation and Dysbiosis
- (2020) Thomas E. Van Dyke et al. Frontiers in Immunology
- Brd2/4 and Myc regulate alternative cell lineage programmes during early osteoclast differentiation in vitro
- (2020) Valentina S. Caputo et al. iScience
- BET Bromodomain Inhibitors Suppress Inflammatory Activation of Gingival Fibroblasts and Epithelial Cells From Periodontitis Patients
- (2019) Anna Maksylewicz et al. Frontiers in Immunology
- BET bromodomains’ functions in bone-related pathologies
- (2019) Camille Jacques et al. Epigenomics
- Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation
- (2017) Ka Lung Cheung et al. MOLECULAR CELL
- Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208)
- (2017) Sylwia Wasiak et al. Journal of Cardiovascular Translational Research
- Interplay of Toll-Like Receptor 9, Myeloid Cells, and Deubiquitinase A20 in Periodontal Inflammation
- (2016) Katie E. Crump et al. INFECTION AND IMMUNITY
- Resolvin E1 Reverses Experimental Periodontitis and Dysbiosis
- (2016) Chun-Teh Lee et al. JOURNAL OF IMMUNOLOGY
- Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial
- (2016) Andrew L. Siebel et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Nonselective inhibition of the epigenetic transcriptional regulator BET induces marked lymphoid and hematopoietic toxicity in mice
- (2016) Dong U. Lee et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
- (2016) Céline Berthon et al. Lancet Haematology
- Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial
- (2015) Stephen J. Nicholls et al. American Journal of Cardiovascular Drugs
- Epigenetic Modifications of Histones in Periodontal Disease
- (2015) M.D. Martins et al. JOURNAL OF DENTAL RESEARCH
- Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice
- (2015) Josefa M. Sullivan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice
- (2014) Ravi Jahagirdar et al. ATHEROSCLEROSIS
- Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression
- (2014) Mar Gacias et al. CHEMISTRY & BIOLOGY
- BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction
- (2014) S. Meng et al. JOURNAL OF DENTAL RESEARCH
- RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist
- (2014) Kevin G. McLure et al. PLoS One
- Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation
- (2014) Kyung-Hyun Park-Min et al. Nature Communications
- BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
- (2013) A. C. Belkina et al. JOURNAL OF IMMUNOLOGY
- Establishment and characterization of a telomerase immortalized human gingival epithelial cell line
- (2013) C. E. Moffatt-Jauregui et al. JOURNAL OF PERIODONTAL RESEARCH
- RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
- (2013) S. Picaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The periodontal pathogen Porphyromonas gingivalis induces the Epstein–Barr virus lytic switch transactivator ZEBRA by histone modification
- (2011) Kenichi Imai et al. BIOCHIMIE
- Two-pronged Binding with Bromodomain-containing Protein 4 Liberates Positive Transcription Elongation Factor b from Inactive Ribonucleoprotein Complexes
- (2011) Sebastian Schröder et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Basis and Specificity of Acetylated Transcription Factor GATA1 Recognition by BET Family Bromodomain Protein Brd3
- (2011) R. Gamsjaeger et al. MOLECULAR AND CELLULAR BIOLOGY
- Epigenetic regulation of human β-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria
- (2011) L Yin et al. Mucosal Immunology
- Suppression of inflammation by a synthetic histone mimic
- (2010) Edwige Nicodeme et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started